Industry Recognition

Welldoc's President and CEO, Kevin McRaith, is quoted in the "Scrip Asks" column, which highlights perspectives from corporate leaders on what 2023 holds therapeutic advances in the biopharma industry....
Scrip Pharma Intelligence
The Wall Street Journal's Pro Venture Capital features Welldoc and CEO and President Kevin McRaith. The article highlights Welldoc's leadership in the digital health and digital therapeutics space, and ability to continually adapt its business model and product offerings to meet the evolving healthcare market....
155 1551116 the wall street journal wall street journal logo 1

Subscribe for Updates

Media Inquiries

For media inquiries, please email

Taking Diabetes Self-Management to the Next Level